BioMed Realty Trust, Inc. (BMR) Misses Q3 FFO by 1c; Narrows FY11 Outlook, Guides FY12 FFO
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $5.52 -4.83%
Financial Fact:
Depreciation and amortization: 64.95M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Depreciation and amortization: 64.95M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q3 FFO of $0.29, $0.01 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $115 million versus the consensus estimate of $109.1 million.
Aees FY2012 FFO of $1.23-$1.33, versus the consensus of $1.28.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.17-$1.19, versus the consensus of $1.19.
Aees FY2012 FFO of $1.23-$1.33, versus the consensus of $1.28.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.17-$1.19, versus the consensus of $1.19.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Procter & Gamble (PG) Tops Q3 EPS by 11c, Revenues Miss
- Huntington Bancshares (HBAN) Tops Q1 EPS by 4c
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
